| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±5.0% | +19.3% | under-priced |
| 04/29/2026 | ±3.3% | -3.5% | under-priced |
| 02/26/2026 | ±2.8% | -6.9% | under-priced |
| 10/30/2025 | ±3.7% | -16.6% | under-priced |
| 07/31/2025 | ±3.2% | -1.9% | over-priced |
| 04/30/2025 | ±3.9% | -3.0% | over-priced |
| 02/26/2025 | ±4.3% | +5.7% | under-priced |
| 10/31/2024 | ±2.4% | +3.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $9.06 | $5.2B | $404M |
| Q1 FY2026 | $6.84 | $4.6B | $305M |
| Q4 FY2025 | — | $4.5B | $435M |
| Q3 FY2025 | $6.57 | $4.3B | $295M |
EME (EME) reports in 2 days, with the next report estimated for 10/29/2026. Across the last 8 reports, options priced an average ±3.6% earnings move while the stock actually moved 7.5% on average — the market has tended to under-price EME's earnings risk. Fundamentals into the print: EPS up 34.8% year-over-year, revenue up 19.8%. QuantLogix's live 5-factor engine currently reads EME as a underweight at 45/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →